+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 5mnj | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
タイトル | Structure of MDM2-MDMX-UbcH5B-ubiquitin complex | |||||||||
![]() |
| |||||||||
![]() | LIGASE / Ubiquitin ligase | |||||||||
機能・相同性 | ![]() cellular response to vitamin B1 / response to formaldehyde / response to water-immersion restraint stress / response to ether / traversing start control point of mitotic cell cycle / fibroblast activation / atrial septum development / regulation of protein catabolic process at postsynapse, modulating synaptic transmission / (E3-independent) E2 ubiquitin-conjugating enzyme / heart valve development ...cellular response to vitamin B1 / response to formaldehyde / response to water-immersion restraint stress / response to ether / traversing start control point of mitotic cell cycle / fibroblast activation / atrial septum development / regulation of protein catabolic process at postsynapse, modulating synaptic transmission / (E3-independent) E2 ubiquitin-conjugating enzyme / heart valve development / Trafficking of AMPA receptors / receptor serine/threonine kinase binding / peroxisome proliferator activated receptor binding / negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator / positive regulation of vascular associated smooth muscle cell migration / negative regulation of protein processing / SUMO transferase activity / hypothalamus gonadotrophin-releasing hormone neuron development / response to steroid hormone / NEDD8 ligase activity / AKT phosphorylates targets in the cytosol / response to iron ion / atrioventricular valve morphogenesis / female meiosis I / positive regulation of protein monoubiquitination / endocardial cushion morphogenesis / fat pad development / cellular response to peptide hormone stimulus / mitochondrion transport along microtubule / ventricular septum development / E2 ubiquitin-conjugating enzyme / positive regulation of muscle cell differentiation / regulation of postsynaptic neurotransmitter receptor internalization / female gonad development / SUMOylation of ubiquitinylation proteins / cardiac septum morphogenesis / blood vessel development / seminiferous tubule development / ligase activity / cellular response to alkaloid / Constitutive Signaling by AKT1 E17K in Cancer / regulation of protein catabolic process / negative regulation of signal transduction by p53 class mediator / male meiosis I / negative regulation of DNA damage response, signal transduction by p53 class mediator / ubiquitin conjugating enzyme activity / SUMOylation of transcription factors / response to magnesium ion / positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator / cellular response to UV-C / protein sumoylation / cellular response to actinomycin D / blood vessel remodeling / cellular response to estrogen stimulus / protein localization to nucleus / ribonucleoprotein complex binding / protein K48-linked ubiquitination / protein autoubiquitination / energy homeostasis / positive regulation of vascular associated smooth muscle cell proliferation / regulation of neuron apoptotic process / neuron projection morphogenesis / regulation of proteasomal protein catabolic process / Maturation of protein E / NPAS4 regulates expression of target genes / Maturation of protein E / ER Quality Control Compartment (ERQC) / Myoclonic epilepsy of Lafora / FLT3 signaling by CBL mutants / Prevention of phagosomal-lysosomal fusion / IRAK2 mediated activation of TAK1 complex / transcription repressor complex / Alpha-protein kinase 1 signaling pathway / Glycogen synthesis / IRAK1 recruits IKK complex / IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation / Endosomal Sorting Complex Required For Transport (ESCRT) / Membrane binding and targetting of GAG proteins / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Negative regulation of FLT3 / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation / Constitutive Signaling by NOTCH1 HD Domain Mutants / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / NOTCH2 Activation and Transmission of Signal to the Nucleus / TICAM1,TRAF6-dependent induction of TAK1 complex / TICAM1-dependent activation of IRF3/IRF7 / APC/C:Cdc20 mediated degradation of Cyclin B / Regulation of FZD by ubiquitination / Downregulation of ERBB4 signaling / APC-Cdc20 mediated degradation of Nek2A / p75NTR recruits signalling complexes / InlA-mediated entry of Listeria monocytogenes into host cells / TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling / TRAF6-mediated induction of TAK1 complex within TLR4 complex / positive regulation of mitotic cell cycle / Regulation of pyruvate metabolism / NF-kB is activated and signals survival / Regulation of innate immune responses to cytosolic DNA / regulation of heart rate 類似検索 - 分子機能 | |||||||||
生物種 | ![]() | |||||||||
手法 | ![]() ![]() ![]() | |||||||||
![]() | Klejnot, M. / Huang, D.T. | |||||||||
資金援助 | ![]()
| |||||||||
![]() | ![]() タイトル: Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity. 著者: Nomura, K. / Klejnot, M. / Kowalczyk, D. / Hock, A.K. / Sibbet, G.J. / Vousden, K.H. / Huang, D.T. | |||||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 150.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 115.2 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 497.7 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 505.5 KB | 表示 | |
XML形式データ | ![]() | 26.6 KB | 表示 | |
CIF形式データ | ![]() | 36.7 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
2 | ![]()
| ||||||||
単位格子 |
|
-
要素
-タンパク質 , 4種, 8分子 AEBFCGDH
#1: タンパク質 | 分子量: 16851.381 Da / 分子数: 2 / 変異: S22R, C85K / 由来タイプ: 組換発現 詳細: K85 in Chains A and E form isopeptide linkage with the carbonyl carbon of G76 in Chains B and F, respectively. 由来: (組換発現) ![]() ![]() ![]() 参照: UniProt: P62837, E2 ubiquitin-conjugating enzyme, (E3-independent) E2 ubiquitin-conjugating enzyme #2: タンパク質 | 分子量: 8922.141 Da / 分子数: 2 / 由来タイプ: 組換発現 詳細: gsggs linker at the N-terminus resulted from cloning. G76 in chain B is covalently linked to K85 side chain in Chain A. 由来: (組換発現) ![]() ![]() ![]() #3: タンパク質 | 分子量: 9668.399 Da / 分子数: 2 / 由来タイプ: 組換発現 詳細: Contains N-terminal His-tag followed by TEV protease cleavage site that was not removed during purification. MDM2 contains 428-491. 由来: (組換発現) ![]() ![]() ![]() 参照: UniProt: Q00987, 合成酵素; C-N結合を形成; 酸-D-アミノ酸リガーゼ(ペプチド合成) #4: タンパク質 | 分子量: 7207.716 Da / 分子数: 2 / 由来タイプ: 組換発現 / 詳細: MDMX contains 427-490 / 由来: (組換発現) ![]() ![]() ![]() |
---|
-非ポリマー , 3種, 87分子 




#5: 化合物 | ChemComp-ZN / #6: 化合物 | #7: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.31 Å3/Da / 溶媒含有率: 46.84 % |
---|---|
結晶化 | 温度: 292 K / 手法: 蒸気拡散法, ハンギングドロップ法 詳細: 0.1 M Tris-HCl, pH 8.5, 0.175 M Li2SO4 and 16-20 %(v/v) PEG 3350 |
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: DECTRIS PILATUS 6M / 検出器: PIXEL / 日付: 2013年2月21日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.97879 Å / 相対比: 1 |
反射 | 解像度: 2.16→50.5 Å / Num. obs: 37881 / % possible obs: 95.3 % / 冗長度: 3.2 % / Net I/σ(I): 6.8 |
-
解析
ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: 3ZNI and 3VJF 解像度: 2.16→50.49 Å / SU ML: 0.59 / 交差検証法: FREE R-VALUE / σ(F): 1.96 / 位相誤差: 30.25
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 減衰半径: 0.95 Å / VDWプローブ半径: 1.2 Å / Bsol: 46.114 Å2 / ksol: 0.336 e/Å3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.16→50.49 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル |
|